ETF profile
Amundi Global Bioenergy UCITS ETF EUR Acc logo

Amundi Global Bioenergy UCITS ETF EUR Acc (WDNR.DE)

ETF overview

The Amundi Global Bioenergy UCITS ETF EUR Acc aims to closely mirror the performance of the Bloomberg BioEnergy Screened Index (the "Index"), regardless of market fluctuations. A core objective is to minimize any divergence between the Sub-Fund's net asset value and the Index's movements. Information concerning the anticipated level of this tracking error, under normal market circumstances, can be found in the Sub-Fund's prospectus. For more in-depth details, investors are encouraged to consult the fund's prospectus or Key Information Document (KID).

CountryLU
ExchangeXETRA
Trades inEUR
Current price
561.90 EUR+0.21%
Close 21 Oct 2026
Interval
Benchmarks

Fund facts

Expense ratio
0.35%
Fund assets
150.27M USD (all share classes)
Issuer
Amundi
Inception date
Jan 30, 2018
Number of holdings
29

Breakdown

Holdings (29)

NameTickerWeight
HF SINCLAIR CORPDINO8.93%
VALERO ENERGY CORPORATIONVLO8.79%
PHILLIPS 66PSX8.12%
UPM-KYMMENE OYJUPM.HE6.88%
NOVONESIS (NOVOZYMES) BNSIS-B.CO6.87%
ARCHER-DANIELS-MIDLAND COADM6.85%
ENI SPA MILANENI.MI6.79%
NESTE OYJNESTE.HE6.33%
BUNGE GLOBAL SABG6.32%
DARLING INGREDIENTS INCDAR6.17%
and 16 more

Historical returns do not guarantee future returns. This is not investment advice.

Amundi Global Bioenergy UCITS ETF EUR Acc (WDNR.DE)

WDNR.DE · XETRA
561.90 EUR+0.21%
Sign up to track this ETF
Benchmarks
Fund facts
Expense ratio
0.35%
Fund assets
150.27M USD (all share classes)
Issuer
Amundi
Inception date
Jan 30, 2018
Number of holdings
29
Breakdown
Holdings (29)
NameTickerWeight
HF SINCLAIR CORPDINO8.93%
VALERO ENERGY CORPORATIONVLO8.79%
PHILLIPS 66PSX8.12%
UPM-KYMMENE OYJUPM.HE6.88%
NOVONESIS (NOVOZYMES) BNSIS-B.CO6.87%
ARCHER-DANIELS-MIDLAND COADM6.85%
ENI SPA MILANENI.MI6.79%
NESTE OYJNESTE.HE6.33%
BUNGE GLOBAL SABG6.32%
DARLING INGREDIENTS INCDAR6.17%
and 16 more
ETF overview

The Amundi Global Bioenergy UCITS ETF EUR Acc aims to closely mirror the performance of the Bloomberg BioEnergy Screened Index (the "Index"), regardless of market fluctuations. A core objective is to minimize any divergence between the Sub-Fund's net asset value and the Index's movements. Information concerning the anticipated level of this tracking error, under normal market circumstances, can be found in the Sub-Fund's prospectus. For more in-depth details, investors are encouraged to consult the fund's prospectus or Key Information Document (KID).

CountryLU
Trades inEUR

Historical returns do not guarantee future returns. This is not investment advice.

Unlock all ETF data

Sign up for Free

Unlock all ETF data

Sign up for Free